Electrochemical nanobiosensor based on reduced graphene oxide and gold nanoparticles for ultrasensitive detection of microRNA-128
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.109960 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Javad Mohammadnejad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran. Electronic address: …. Hauptthemen laut MEDLINE: MicroRNAs, Metal Nanoparticles, Biosensing Techniques. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universidad de Alcalá, Comunidad de Madrid.
Abstract (Originalsprache)
Acute lymphoblastic leukemia (ALL) is one of the most prevalent cancers in children and microRNA-128 is amongst the most useful biomarkers not only for diagnosis of ALL, but also for discriminating ALL from acute myeloid leukemia (AML). In this study, a novel electrochemical nanobiosensor based on reduced graphene oxide (RGO) and gold nanoparticles (AuNPs) has been fabricated to detect miRNA-128. Cyclic Voltametery (CV), Square Wave Voltametery (SWV) and Electrochemical Impedance Spectroscopy (EIS) have been applied to characterize the nanobiosensor. Hexacyanoferrate as a label-free and methylene blue as a labeling material were used in the design of the nanobiosensors. It was found that the modified electrode has excellent selectivity and sensitivity to miR-128, with a limit of detection of 0.08761 fM in label-free and 0.00956 fM in labeling assay. Additionally, the examination of real serum samples of ALL and AML patients and control cases confirms that the designed nanobiosensor has the potential to detect and discriminate these two cancers and the control samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran. Electronic address: mohamadnejad@ut.ac.ir.
- Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran.
- Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran. Electronic address: yazdian@ut.ac.ir.
- Department of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran, Iran.
- Protein Research Center, Shahid Beheshti University, G. C., Velenjak, Tehran, Iran. Electronic address: J_shabani@sbu.ac.ir.
- Protein Research Center, Shahid Beheshti University, G. C., Velenjak, Tehran, Iran. Electronic address: m_omidi@sbmu.ac.ir.
Förderung
- Universidad de Alcalá
- Comunidad de Madrid
Zitieren
APA
Mohammadnejad, J., Basirhaghighi, N., Yazdian, F., Pourmadadi, M., Shayeh, J. S., Omidi, M., Mirshafiei, M., Rahdar, A., & Díez-Pascual, A. M. (2023). Electrochemical nanobiosensor based on reduced graphene oxide and gold nanoparticles for ultrasensitive detection of microRNA-128. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109960
Vancouver
Mohammadnejad J, Basirhaghighi N, Yazdian F, Pourmadadi M, Shayeh JS, Omidi M, et al. Electrochemical nanobiosensor based on reduced graphene oxide and gold nanoparticles for ultrasensitive detection of microRNA-128. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109960
BibTeX
@article{Mohammadnejad2023,
author = {Mohammadnejad, Javad and Basirhaghighi, Niki and Yazdian, Fatemeh and Pourmadadi, Mehrab and Shayeh, Javad Shabani and Omidi, Meisam and Mirshafiei, Mojdeh and Rahdar, Abbas and Díez-Pascual, Ana M},
title = {Electrochemical nanobiosensor based on reduced graphene oxide and gold nanoparticles for ultrasensitive detection of microRNA-128},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.109960}
}
EUVIMED